Lantern Pharma Inc.
Lantern Pharma Inc. (LTRN) Revenue
Annual & quarterly revenue history · segment & region breakdown
LTRN · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsLantern Pharma Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Lantern Pharma Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Lantern Pharma Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Lantern Pharma Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LTRN revenue · 4 questionsLTRN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Lantern Pharma Inc. SEC filings · GAAP · Lantern Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026